Vigorous intermittent lifestyle physical activity associated with reduction of all-cause mortality, cancer, and cardiovascular mortality NatureMedicine Sydney_Uni UofGlasgow UniofOxford ucl cancer mortality exercise physicalactivity
By Neha MathurDec 13 2022Reviewed by Danielle Ellis, B.Sc. In a recent article published in Nature Medicine, researchers investigated the health-enhancing effects of vigorous intermittent lifestyle physical activity if incorporated into the daily lives of non-exercisers unable to indulge in vigorous physical activity .
Regardless of the domain, physical activity reduces the risk of all-cause mortality, plus mortality due to cardiovascular diseases and specific cancers. Thus, there is an urgent need for studies examining the associations of VILPA with all-cause mortality, including CVDs and cancers in non-exercisers. Wearable devices could capture ‘micro-patterns’ of VILPA, which could help better understand its effect on non-exercisers health.
Study findings The study cohort comprised 25241 individuals, of whom 14,178 were women, and the remaining 11,063 were men; all had an average age of 61.8 years. The average follow-up duration of the study was 6.9 years. The researchers noted that engaging in more VILPA for about four to five minutes per day led to more mortality risk reductions across all three outcomes assessed in the study in a non-linear fashion.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers smell a cryptomining Chaos RAT targeting LinuxResearchers smell a cryptomining Chaos RAT targeting Linux systems
Read more »
Clinical efficacy and safety of two injections of a bivalent vaccine as a primary series during a period of Omicron circulationClinical efficacy and safety of two injections of a bivalent vaccine as a primary series during a period of Omicron circulation medrxivpreprint EmoryUniversity harvardmed fredhutch HopkinsMedicine vaccine vaccination COVID19 coronavirus covid
Read more »
Alcoholics to be given ketamine to see if it reduces alcohol useAlcoholics will be given ketamine-assisted therapy as part of a £2.4 million phase three trial to see if it helps them stay off alcohol for longer.
Read more »
Overview of current methods, technologies, and applications in the molecular diagnosis of mpoxOverview of current methods, technologies, and applications in the molecular diagnosis of mpox medrxivpreprint ufmg StudentsNCL mpox virus diagnosis moleculardiagnosis diagnostics
Read more »
What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals?What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals? medrxivpreprint UUtah UCSF DukeMedSchool nyugrossman symptoms riskfactor longcovid covid COVID19 SARSCoV2
Read more »
Research reveals the assembly dynamics of nucleocapsid protein condensates can be regulated by small molecules with therapeutic potentialResearch reveals the assembly dynamics of nucleocapsid protein condensates can be regulated by small molecules with therapeutic potential biorxivpreprint harvardmed Harvard virus coronavirus humancoronaviruses protein nucleocapsidprotein
Read more »